BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+19.15%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.8B
AUM Growth
+$2.8B
(+14%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-8.49%
Top 10 Holdings %
Top 10 Hldgs %
76.91%
Holding
52
New
1
Increased
5
Reduced
8
Closed
8
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$35.2M |
| 2 |
Immunocore
IMCR
|
$32.1M |
| 3 |
Kymera Therapeutics
KYMR
|
$14.9M |
| 4 |
Verastem
VSTM
|
$5.41M |
| 5 |
TScan Therapeutics
TCRX
|
$488K |
Top Sells
| 1 |
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
|
$132M |
| 2 |
RAPT Therapeutics
RAPT
|
$64.7M |
| 3 |
Galapagos
GLPG
|
$36.5M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$31.6M |
| 5 |
iTeos Therapeutics
ITOS
|
$18.4M |
Sector Composition
| 1 | Healthcare | 99.98% |